The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials

Human Vaccines & Immunotherapeutics
Ellen SuderEmmie de Wit

Abstract

The devastating Ebola virus (EBOV) epidemic in West Africa in 2013-2016 accelerated the progress of several vaccines and antivirals through clinical trials, including the replication-competent vesicular stomatitis virus-based vaccine expressing the EBOV glycoprotein (VSV-EBOV). Extensive preclinical testing in animal models demonstrated the prophylactic and post-exposure efficacy of this vaccine, identified the mechanism of protection, and suggested it was safe for human use. Based on these data, VSV-EBOV was extensively tested in phase 1-3 clinical trials in North America, Europe and Africa. Although some side effects of vaccination were observed, these clinical trials showed that the VSV-EBOV was safe and immunogenic in humans. Moreover, the data supported the use of VSV-EBOV as an emergency vaccine in individuals at risk for Ebola virus disease. In this review, we summarize the results of the extensive preclinical and clinical testing of the VSV-EBOV vaccine.

References

May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·N D LawsonJ K Rose
May 4, 2004·Trends in Molecular Medicine·Brian D LichtyJohn C Bell
Jun 24, 2005·PLoS Medicine·Thomas W GeisbertHeinz Feldmann
Jan 24, 2007·PLoS Pathogens·Heinz FeldmannThomas W Geisbert
Dec 6, 2007·The Journal of Infectious Diseases·Steven M JonesHeinz Feldmann
Oct 19, 2011·The Journal of Infectious Diseases·Andrea MarziHeinz Feldmann
Oct 19, 2011·The Journal of Infectious Diseases·Stephan GüntherStefan Schmiedel
Jan 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrea MarziIlhem Messaoudi
Dec 25, 2013·PLoS Neglected Tropical Diseases·Chad E MireThomas W Geisbert
Jan 28, 2015·Emerging Infectious Diseases·Andrea MarziDavid Safronetz
Mar 27, 2015·Emerging Infectious Diseases·Emmie de WitHeinz Feldmann
Apr 2, 2015·The New England Journal of Medicine·Jason A RegulesUNKNOWN rVSVΔG-ZEBOV-GP Study Group
Apr 2, 2015·The New England Journal of Medicine·Selidji T AgnandjiClaire-Anne Siegrist
May 11, 2015·The Journal of Infectious Diseases·Chad E MireJohn H Connor
May 26, 2015·Expert Opinion on Drug Discovery·Amy C Shurtleff, Sina Bavari
Apr 15, 2016·Expert Review of Vaccines·Chad E MireAndrea Marzi
Apr 28, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen K WongTimothy M Uyeki
Jul 9, 2016·MMWR Supplements·Marc-Alain WiddowsonAnne Schuchat
Apr 14, 2017·Science Translational Medicine·Angela HuttnerClaire-Anne Siegrist
Apr 25, 2017·EBioMedicine·Christine DahlkeUNKNOWN VEBCON Consortium
Apr 28, 2017·Virus Genes·Pierce Reynolds, Andrea Marzi
Jun 21, 2017·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·May S ElSherifUNKNOWN Canadian Immunization Research Network
Jun 28, 2017·Current Topics in Microbiology and Immunology·Satoko YamaokaHideki Ebihara
Oct 12, 2017·The New England Journal of Medicine·Stephen B KennedyUNKNOWN PREVAIL I Study Group

❮ Previous
Next ❯

Citations

Feb 20, 2019·Expert Review of Vaccines·Thomas GerlachGuus F Rimmelzwaan
Jan 3, 2019·Expert Review of Vaccines·Christiane GerkeFrédéric Tangy
Oct 10, 2018·Expert Review of Vaccines·Natalie A ProwAndreas Suhrbier
Jan 19, 2019·Journal of Travel Medicine·Blaise Genton
Sep 25, 2019·Pharmaceuticals·Lamin B ChamJudith Bezgovsek
Jul 10, 2018·The Journal of Infectious Diseases·Michael R Holbrook
Jan 8, 2020·Tropical Medicine and Infectious Disease·John Goldsmid, Silvana Bettiol
Jul 1, 2020·Expert Opinion on Biological Therapy·Altar M MunisYasuhiro Takeuchi
Aug 25, 2020·Current Protocols in Microbiology·Alaa A Abdelmageed, Maureen C Ferran
Jul 26, 2019·Nature Reviews. Microbiology·Thomas HoenenHeinz Feldmann
Oct 1, 2019·Annual Review of Virology·Wakako Furuyama, Andrea Marzi
Nov 18, 2018·Viruses·Himanshu GargAnjali Joshi
Feb 19, 2020·Expert Opinion on Biological Therapy·Matthew ChiuAlan Melcher
Sep 12, 2018·Annual Review of Microbiology·Heinz FeldmannAndrea Marzi
Oct 9, 2019·Nature Medicine·Stefanie A EhrhardtFlorian Klein
Feb 2, 2021·International Journal of Rheumatic Diseases·Swetha ByravanArumugam Moorthy
Dec 18, 2020·Nature Communications·Yfat Yahalom-RonenTomer Israely
Jun 22, 2020·European Journal of Medicinal Chemistry·Chengyuan LiangXu Zhao
Mar 1, 2021·Vaccine·Jonas B Sandbrink, Gregory D Koblentz
Apr 20, 2021·Current Opinion in Immunology·Oyewale Tomori, Matthew Olatunji Kolawole
May 23, 2021·Microbes and Infection·Pin-Yu Perera, Liyanage P Perera
Aug 22, 2021·NPJ Vaccines·Marie-Angélique SèneAmine A Kamen
Oct 7, 2021·Comparative Medicine·Jacqueline K Brockhurst, Jason S Villano

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02269423
NCT02280408
NCT02283099
NCT02296983
NCT02344407
NCT02378753
NCT02503202

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.